Munich Re and Microsoft helped CO2-to-chemicals technology provider Twelve raise $57m while Eli Lilly and Kaiser Permanente-backed CRO dMed-Clinipac secured $50m.

NTT Docomo Ventures and 31Ventures returned for the smart key system provider’s $15.8m round, which included Kokuyo, NN Corporate Capital and JR East Start Up.

Drug discovery technology developer Standigm added $10m to the cash it raised from SK Chemicals last week while Six FinTech Ventures helped fintech software provider Toqio secure $9.4m.

Marubeni and SBI have co-led a $15.3m round for the Mongolia-focused mobile credit app developer, investing alongside existing shareholder Techstars Ventures.

Nationwide helped the open finance business raise $18m which will be used to boost expansion in Europe and accelerate its growth across the wealth, insurance and retail spaces.

Santander’s independent venture capital spinoff has led a series B round for byrd, which increased the business’ total funding to $30.8m.

Eli Lilly has agreed to make an equity investment in Mina Therapeutics after approving a research collaboration with the saRNA drug developer earlier this year.

The AI semiconductor technology developer's debut funding round was co-led by SIG China and will fund hiring, R&D and market expansion.

On-demand logistics provider Pickupp hiked its overall funding to $15m while SK Chemicals added to the $67m already raised by drug discovery technology producer Standigm.

GV helped geometric search technology developer Physna raise $56m while multiple corporates took part in a round nearly doubling study app developer Mathpresso's total funding to $105m.